Mathematical modeling reveals alternative JAK inhibitor treatment in myeloproliferative neoplasms.

Overview

authors

Koppikar, Priya

Teruya-Feldstein, Julie

Csete, Isabelle

Keller, Matthew

Kilpivaara, Outi

Michor, Franziska

Levine, Ross L.
de Vargas Roditi, Laura

publication date

August 14, 2019

published in

Haematologica Journal

Research

keywords

Janus Kinase Inhibitors
Myeloproliferative Disorders
Neoplasms

Identity

PubMed Central ID

PMC7049364

Scopus Document Identifier

85080892032

Digital Object Identifier (DOI)

10.3324/haematol.2018.203729

PubMed ID

31413098

Additional Document Info

volume

105

issue

3